Status:
COMPLETED
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Testicular Cancer
Seminoma
Eligibility:
MALE
18+ years
Brief Summary
For many years, researchers and doctors have studied different kinds of treatments to improve the survival of men with testicular cancer. However, recent research has shown that many years later, men ...
Detailed Description
The aim of this pilot study is to examine global and regional LV systolic and diastolic function, cardiac output, cardiac reserve, VO2peak and CVD risk profile in males recently diagnosed with testicu...
Eligibility Criteria
Inclusion
- surgery and surveillance
- surgery and multi-cycle chemotherapy
- both good and intermediate prognosis seminoma and non-seminomatous germ cell testicular tumors
- Karnofsky performance index \> 70%
- no contraindications to cardiopulmonary testing
Exclusion
- documented cardiovascular disease or evidence of myocardial ischemia on the incremental exercise (VO2peak) test.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00705094
Start Date
September 1 2008
End Date
July 1 2012
Last Update
October 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2